CompoAtlas

ReAge Femeno 2

Food supplement declared in France, declaration No 2019-10-321, decision dated 9 October 2019

ReAge Femeno 2, from Re-Age Health Supplements BV, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Brassica oleracea 250 mg per day, Pantothenic acid (vitamin B5), Vitamin B6, Glutathion, Bétaïne. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Re-Age Health Supplements BV
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 capsules
Intended populations
Women
Not recommended (according to the manufacturer)
Children (under 12), Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Menopause

Declaration 298108, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Brassica oleracea L.FeuilleExtrait fluide hydroalcoolique250 mg

Other active ingredients

NamePer day
Glutathionnot declared
Bétaïnenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg

Additives

Hydroxypropyl Méthyl Cellulose, E341, E470b, E551

Other ingredients

fécule de pomme de terre

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas dépasser la dose journalière recommandée. Ne pas administrer aux enfants de moins de 12 ans. Consultez votre médecin au sujet des instructions d’utilisation et de la période d’administration. Consultez votre médecin en cas de glande thyroïde à action lente (hypothyroïdie) et/ou d’utilisation concomitante de médicaments pour la thyroïde. Les compléments alimentaires ne peuvent pas se substituer à une alimentation variée. Une alimentation variée et équilibrée et un mode de vie sain sont primordiaux.Tenir hors de la portée des jeunes enfants. Conserver dans un endroit sec, frais et sombre.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Bétaïne
    Read the warning, when it applies and the studies cited

    BETAINE / BETAINE HYDROCHLORIDE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products containing Betaine hydrochloride (as a medicinal ingredient or as a source ingredient).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer or excess stomach acid (RSC 2024; Hendler and Rorvik 2008).

    Sources cited by Health Canada (2)
    • Hendler SS, Rorvik DM. PDR® for Nutritional Supplements, 2nd edition. Thomson Reuters. Physicians' Desk References Inc., NJ; 2008.
    • RSC 2024: Royal Society of Chemistry: The Merck Index Online [Accessed 2024 June 20]. Available from: https://merckindex.rsc.org/

    Applies to products providing 600 milligrams or more of Betaine or 780 milligrams or more of Betaine hydrochloride as a medicinal ingredient, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high cholesterol (Olthof et al. 2005; Swab et al. 2002).

    Sources cited by Health Canada (2)
    • Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in health humans. PLoS Medicine 2005;2(5):e135. PubMed Randomised trial
    • Swab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. American Journal of Clinical Nutrition 2002;76:961-967.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “ReAge Femeno 2: composition and regulation”, https://compoatlas.com/en/supplements/products/298108-reage-femeno-2, updated 15 November 2026.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line